跳至主要内容
临床试验/ISRCTN77119437
ISRCTN77119437
已完成
未知

Comparison of post-operative function following MAKOplasty® unicondylar knee arthroplasty, using MAKOplasty® and the MAKO RIO® System, versus OXFORD® partial knee arthroplasty

HS Greater Glasgow and Clyde (UK)0 个研究点目标入组 139 人2010年2月5日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Early-mid stage osteoarthritis of the knee
发起方
HS Greater Glasgow and Clyde (UK)
入组人数
139
状态
已完成
最后更新
3年前

概览

简要总结

2016 Results article in https://www.ncbi.nlm.nih.gov/pubmed/27098321 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29162608 results 2018 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/29524796 1-year outcomes 2018 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/29627257 2-year outcomes 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34058870/ five-year outcomes (added 02/06/2021)

注册库
who.int
开始日期
2010年2月5日
结束日期
2023年1月31日
最后更新
3年前
研究类型
Interventional
性别
All

研究者

发起方
HS Greater Glasgow and Clyde (UK)

入排标准

入选标准

  • 1\. Male or female subjects may be recruited to the evaluation
  • 2\. Age \- there are no restrictions relating to age of the patient. The patient's age must be considered suitable by the clinical investigator for a unicondylar knee arthroplasty using either of the two systems available in the evaluation.
  • 3\. Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained
  • 4\. Subjects who, in the opinion of the Investigator, are able to understand this investigation, co\-operate with the investigation procedures and are willing to return to the hospital for all the required post\-operative follow\-ups
  • 5\. Subjects who require a unicondylar knee arthroplasty for primary surgical management of idiopathic osteoarthritis
  • 6\. Patients who in the opinion of the Chief Investigator are considered to be suitable for treatment with a MAKOplasty® and OXFORD® unicondylar knee replacement

排除标准

  • 1\. Patients who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow\-up in the study
  • 2\. Patients who require revision knee arthroplasty surgery
  • 3\. Patients with any tibial deformity requiring tibial component augmentation
  • 4\. Patients whom, in the opinion of the Chief Investigator, require a total knee prosthesis
  • 5\. Patients with inflammatory polyarthritis
  • 6\. Disorders of the feet, ankles, hips or spine causing significant abnormal gait or significant pain
  • 7\. Neurological conditions affecting movement
  • 8\. Patients with a pathology which, in the opinion of the Chief Investigator, will adversely affect healing
  • 9\. Patients with other disorders which, in the opinion of the Chief Investigator, will/could impair rehabilitation
  • 10\. Contra\-indications for use of the device, as detailed in the package insert

结局指标

主要结局

未指定

相似试验